Acadia names Walgreens EVP/CFO to board | Behavioral Healthcare Executive Skip to content Skip to navigation

Acadia names Walgreens EVP/CFO to board

January 31, 2012
by News release
| Reprints
Cick for image.

Acadia Healthcare has named Wade D. Miquelon to its board of directors. Miquelon joined Walgreen Co. in June 2008 as senior vice president and CFO, and has been executive vice president and CFO since July 2009.

Prior to Walgreens, he was executive vice president and CFO at Tyson Foods, Inc. from 2006 to 2008. From 1989 to 2006, Miquelon served Procter & Gamble in a number of positions of increasing responsibility, most recently for three years as vice president of finance for Western Europe, the senior most financial officer responsible for the 17-country Western Europe operation.

Among other positions during his tenure at P&G, Mr. Miquelon was the head of Finance and Accounting for the ASEAN, Australasia, and India region, served as Director and Investment Partner of I Ventures, a P&G venture capital fund, and co-founded and served as CFO and senior vice president of business development/human resources, of Emmperative, Inc., an enterprise marketing management software joint venture between P&G and other entities.

“Wade Miquelon brings tremendous expertise in a range of disciplines to Acadia, as well as valuable perspectives from his work with both large established companies and young growth companies," noted Joey Jacobs, chairman and CEO of Acadia. "We welcome Wade to the board, confident of his ability to contribute to the company’s long-term growth in earnings and shareholder value.”